Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hantavirus Infection, Austria

Area of Science:

• Infectious Diseases
• Pulmonology
• Critical Care Medicine

Background:

• Hantavirus infections, particularly hemorrhagic fever with renal syndrome (HFRS), can lead to severe respiratory complications.
• Invasive pulmonary aspergillosis (IPA) is a life-threatening fungal infection often seen in immunocompromised individuals.
• The co-occurrence of hantavirus and IPA is not well-characterized, especially in critically ill patients.

Purpose of the Study:

• To investigate the incidence and outcomes of invasive pulmonary aspergillosis in a cohort of patients with hantavirus infections.
• To assess the risk factors and clinical presentation of hantavirus-associated pulmonary aspergillosis.
• To understand the implications of IPA on the prognosis of patients with hantavirus-induced HFRS.

Main Methods:

• Retrospective cohort study of 370 patients diagnosed with hantavirus infections in Austria.
• Analysis of patient records to identify cases of invasive pulmonary aspergillosis.
• Evaluation of clinical data, ICU admission rates, treatment, and mortality.

Main Results:

• Two cases (7% cumulative incidence) of invasive pulmonary aspergillosis were detected among the 370 patients.
• One patient with hantavirus-associated pulmonary aspergillosis died.
• A significant proportion of hantavirus patients (7.8%) required intensive care unit (ICU) admission.

Conclusions:

• Invasive pulmonary aspergillosis represents a significant and potentially fatal complication in patients with hantavirus infections, particularly those with HFRS.
• Critically ill patients with hantavirus infections are at risk for developing IPA.
• Early recognition and management of IPA are crucial for improving outcomes in hantavirus patients.